- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07723053
Machine Learning-Guided LIV Selection for Adolescent Idiopathic Scoliosis
A Prospective Randomized Controlled Trial of the Drum Tower Rule Machine Learning Model for Lowest Instrumented Vertebra Selection in Lenke Type 1 and Type 5 Adolescent Idiopathic Scoliosis
This study will evaluate whether a machine learning-based decision support model, called the Drum Tower Rule, can help surgeons select the lowest instrumented vertebra during corrective surgery for adolescent idiopathic scoliosis.
Patients with Lenke type 1 or Lenke type 5 adolescent idiopathic scoliosis who are scheduled for posterior spinal fusion will be randomly assigned to one of two groups. In the model-guided group, surgeons will receive the model-predicted risk of postoperative distal adding-on and a recommendation for lowest instrumented vertebra selection. In the conventional-experience group, surgeons will select the lowest instrumented vertebra according to routine clinical experience and existing surgical principles, without access to the model output.
All patients will receive standard posterior spinal fusion. The main outcome is the incidence of distal adding-on at 24 months after surgery, assessed by blinded radiographic reviewers.
Study Overview
Status
Conditions
Detailed Description
Adolescent idiopathic scoliosis is a common spinal deformity in children and adolescents. For patients requiring corrective surgery, selection of the lowest instrumented vertebra is a key surgical decision. An inappropriate distal fusion level may increase the risk of postoperative distal adding-on, coronal imbalance, unnecessary loss of spinal mobility, or revision surgery.
The Drum Tower Rule is a machine learning-based decision support model developed to estimate the risk of postoperative distal adding-on and assist with lowest instrumented vertebra selection in patients with Lenke type 1 and Lenke type 5 adolescent idiopathic scoliosis. Before the start of this trial, the model, input variables, risk threshold, and software version will be locked and will not be modified during the study.
This is a single-center, prospective, randomized, open-label, parallel-group controlled trial with blinded outcome assessment. Eligible participants will be randomly assigned in a 1:1 ratio to either the model-guided group or the conventional-experience group. Randomization will be stratified by Lenke classification.
In the model-guided group, preoperative clinical and radiographic variables will be entered into the locked machine learning model. The model will generate a predicted risk of distal adding-on and a recommendation for lowest instrumented vertebra selection. For Lenke type 1 patients, the decision will focus on selection between one level proximal to the last substantially touching vertebra and the last substantially touching vertebra. For Lenke type 5 patients, the decision will focus on selection between L3 and L4. The surgeon will make the final decision after considering the model output and clinical judgment.
In the conventional-experience group, the surgeon will select the lowest instrumented vertebra based on routine clinical experience and existing surgical principles. The model output will not be provided to the surgeon for participants in this group.
Both groups will undergo standard posterior spinal fusion with an all-pedicle screw instrumentation system. Postoperative follow-up will be performed at 1 week and at 3, 6, 12, and 24 months after surgery. The primary outcome is the incidence of distal adding-on at 24 months after surgery. Secondary outcomes include number of fused segments, Cobb angle correction rate, coronal balance, sagittal radiographic parameters, Scoliosis Research Society-22 score, visual analog scale score for low back pain, complications, instrumentation failure, revision surgery, and adoption of model recommendations.
The primary outcome will be assessed by independent radiographic reviewers who are blinded to treatment allocation.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Xiaodong Qin, MD, PhD
- Phone Number: 025-68182923
- Email: gyethics@163.com
Study Locations
-
-
Jiangsu
-
Nanjing, Jiangsu, China, 210008
- Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School
-
Contact:
- Xiaodong Qin, MD, PhD
- Phone Number: 025-68182923
- Email: gyethics@163.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Diagnosis of adolescent idiopathic scoliosis classified as Lenke type 1A or Lenke type 5C.
- Age 10 to 18 years, inclusive.
- Scheduled to undergo posterior spinal fusion using an all-pedicle screw instrumentation system.
- Planned selective thoracic fusion or selective lumbar fusion, with a clinical need for lowest instrumented vertebra decision-making.
- Availability of required preoperative standing full-spine radiographs and bending radiographs.
- Ability and willingness to complete the planned 24-month postoperative follow-up.
- Written informed consent provided by the participant and legal guardian.
Exclusion Criteria:
- - Congenital scoliosis, neuromuscular scoliosis, syndromic scoliosis, or other non-idiopathic scoliosis.
- History of spinal trauma, spinal tumor, spinal tuberculosis, or spinal infection.
- Previous spinal surgery.
- Severe sagittal spinal deformity, such as Scheuermann disease, for which the study model is not applicable.
- Neurological symptoms or signs.
- Leg length discrepancy greater than 10 mm.
- The surgeon determines that there is no clinical equipoise for lowest instrumented vertebra selection because one option is clearly contraindicated for safety or anatomical reasons.
- Inability to complete follow-up or required study assessments.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Model-Guided Group
Participants in this group will undergo standard posterior spinal fusion.
Before surgery, preoperative clinical and radiographic variables will be entered into the locked Drum Tower Rule machine learning model.
The model will generate a predicted risk of distal adding-on and a recommendation for lowest instrumented vertebra selection.
The surgeon will make the final decision after considering the model output and clinical judgment.
|
A locked machine learning-based decision support model will be used before surgery to estimate the risk of postoperative distal adding-on and provide a recommendation for lowest instrumented vertebra selection.
The model output will be available to surgeons in the model-guided group only.
All participants will undergo standard posterior spinal fusion using an all-pedicle screw instrumentation system.
|
|
Active Comparator: Conventional-Experience Group
Participants in this group will undergo standard posterior spinal fusion.
The surgeon will select the lowest instrumented vertebra according to routine clinical experience and existing surgical principles.
The Drum Tower Rule model output will not be provided to the surgeon for participants in this group.
|
All participants will undergo standard posterior spinal fusion using an all-pedicle screw instrumentation system.
The lowest instrumented vertebra will be selected by the surgeon according to routine clinical experience and existing surgical principles, without access to the Drum Tower Rule model output.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of Distal Adding-on
Time Frame: 24 months after surgery
|
Distal adding-on is defined as an increase of more than 5 degrees in the disc angle below the lowest instrumented vertebra compared with the immediate postoperative radiograph, or an increase of more than 5 mm in the translation of the vertebra below the lowest instrumented vertebra relative to the central sacral vertical line.
The outcome will be assessed by blinded radiographic reviewers.
|
24 months after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Scoliosis Research Society-22 Score
Time Frame: 24 months after surgery
|
Health-related quality of life will be assessed using the Scoliosis Research Society-22 questionnaire.
|
24 months after surgery
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of Surgery-Related Complications
Time Frame: From surgery to 24 months after surgery
|
Surgery-related complications include perioperative complications, instrumentation failure, proximal junctional kyphosis, adjacent segment degeneration, pseudarthrosis, infection, and revision surgery.
|
From surgery to 24 months after surgery
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Weinstein SL, Dolan LA, Cheng JC, Danielsson A, Morcuende JA. Adolescent idiopathic scoliosis. Lancet. 2008 May 3;371(9623):1527-37. doi: 10.1016/S0140-6736(08)60658-3.
- Lenke LG, Betz RR, Harms J, Bridwell KH, Clements DH, Lowe TG, Blanke K. Adolescent idiopathic scoliosis: a new classification to determine extent of spinal arthrodesis. J Bone Joint Surg Am. 2001 Aug;83(8):1169-81.
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- NDTH-20260578
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Adolescent Idiopathic Scoliosis
-
Lahore University of Biological and Applied SciencesGhurki Trust and Teaching HospitalNot yet recruitingScoliosis Idiopathic | Idiopathic Adolescent ScoliosisPakistan
-
Uppsala UniversityUniversity of Oslo; Linkoeping University; Örebro University, Sweden; Skane University... and other collaboratorsNot yet recruitingIdiopathic Adolescent Scoliosis | Idiopathic Juvenile ScoliosisSweden
-
Hasan Kalyoncu UniversityNot yet recruitingScoliosis Idiopathic | Scoliosis Idiopathic Adolescent | Caregiver AnxietyTurkey (Türkiye)
-
National Scoliosis CenterCompletedAdolescent Idiopathic Scoliosis (AIS) | Neuromuscular Scoliosis | Juvenile Idiopathic Scoliosis | Infantile Idiopathic Scoliosis | Ealy Onset ScoliosisUnited States
-
Hasan Kalyoncu UniversityCompletedScoliosis Idiopathic Adolescent Treatment | Scoliosis Idiopathic AdolescentTurkey (Türkiye)
-
Istinye UniversityCompletedScoliosis Idiopathic Adolescent Treatment | Scoliosis Idiopathic AdolescentTurkey (Türkiye)
-
Hasan Kalyoncu UniversityThe Scientific and Technological Research Council of TurkeyRecruitingScoliosis Idiopathic Adolescent Treatment | Scoliosis Idiopathic AdolescentTurkey
-
University of Colorado, DenverRecruitingAdolescent Idiopathic Scoliosis (AIS) | Neuromuscular ScoliosisUnited States
-
Assistance Publique Hopitaux De MarseilleNot yet recruitingScoliosis Idiopathic AdolescentFrance
-
Hasan Kalyoncu UniversityCompletedAdolescent Idiopathic ScoliosisTurkey (Türkiye)
Clinical Trials on Drum Tower Rule Machine Learning-Guided Decision Support
-
Royal Marsden NHS Foundation TrustImperial College London; Institute of Cancer Research, United KingdomActive, not recruiting
-
UNC Lineberger Comprehensive Cancer CenterAgency for Healthcare Research and Quality (AHRQ)RecruitingCancer | Prostate CancerUnited States
-
University of PittsburghNational Institute on Drug Abuse (NIDA); Applied Decision ScienceActive, not recruitingMental Disorders | Chemically-Induced Disorders | Opioid-Related Disorders | Narcotic-Related Disorders | Substance-related Disorders | Opiate OverdoseUnited States
-
Ostfold Hospital TrustSahlgrenska University HospitalRecruitingDeep Vein ThrombosisNorway